Impact of Risk Assessment and Tailored versus Nontailored Risk Information on Colorectal Cancer Testing in Primary Care: A Randomized Controlled Trial.
Impact of Risk Assessment and Tailored versus Nontailored Risk Information on Colorectal Cancer Testing in Primary Care: A Randomized Controlled Trial.
复制标题
DOI：
10.1158/1055-9965.epi-15-0122
复制
发表时间：
2015-10
期刊：
影响因子：
--
通讯作者：
Rawl SM
中科院分区：
文献类型：
--
作者：
Skinner CS;Halm EA;Bishop WP;Ahn C;Gupta S;Farrell D;Morrow J;Julka M;McCallister K;Sanders JM;Marks E;Rawl SM
Colorectal cancer (CRC) screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations. Randomized controlled trial among patients who: (1) used CRIS and they and their physicians received tailored printouts; (2) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for CRC screening; or (3) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months. Participation in any CRC testing was three times higher for those who used the CRIS and received any printed materials, compared to no-contact controls (47% v. 16%; p < 0.0001). Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53% v. 44%, p=0.023). Use of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than nontailored group. Asking patients questions about their specific risk factors and giving them and their providers’ information just prior to an appointment may increase participation in CRC testing. Tailoring the information has some added benefit.
